With today's greater combination of technology and know-how, we must design new ways to handle sensitive pharmaceuticals—and do it together
Joel Wayment and Jason Cook, Cardinal Health
Advertisement
Articles by Joel Wayment and Jason Cook, Cardinal Health
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
Why Regulatory Sandboxes Offer a Safe Space for AI Innovation in Healthcare
3
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
4
Pharma Pulse: CDC Layoffs Raise Public Health Concerns as Ypsomed and Lupin Expand US Manufacturing Footprint
5
